Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
451.10    1.10 (0.24%)
Bid:
450.60
Ask:
450.70
Spread: 0.10 (0.022%)
Market Cap: £11.35b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

23 Mar 2023 09:42

RNS Number : 0208U
Rentokil Initial PLC
23 March 2023
Β 

Rentokil Initial plc (the "Company")

23 March 2023

Β 

Notification of transactions by persons discharging managerial responsibilities (PDMRs)

Β 

Rentokil Initial plc (the "Company") hereby announces that Andy Ransom, Chief Executive, has exercised his awards of 971,802 ordinary shares granted under the Company Performance Share Plan (PSP) in April and October 2013.Β 

Β 

The awards, which vested in April and October 2016, would both lapse this year if they remained unexercised. 457,308 of these shares have been sold to cover the tax and national insurance liability on the awards at a share price of 559.8605p per share.Β 

Β 

The relevant notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Andy Ransom

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Executive

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Rentokil Initial plc

b)

Β 

LEI

Β 

549300VN4WV7Z6T14K68

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of 1p each

Β 

Β 

ISIN: GB00B082RF11

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Exercise of awards made under the 2013 Performance Share Plan (PSP)

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β 

Nil consideration

Β 

971,802

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

971,802 shares

Β 

-

Β 

e)

Β 

Date of the transaction

Β 

22 March 2023

f)

Β 

Place of the transaction

Β 

Outside a trading venue

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

a)

Β 

Name

Β 

Andy Ransom

Β 

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Executive

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Β 

Name

Β 

Rentokil Initial plc

b)

Β 

LEI

Β 

549300VN4WV7Z6T14K68

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of 1p each

Β 

Β 

ISIN: GB00B082RF11

b)

Β 

Nature of the transaction

Β 

Sale of shares

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

559.8605p

457,308

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Total price

Β 

Β 

Β 

457,308

Β 

Β£2,560,286.86

e)

Β 

Date of the transaction

Β 

22 March 2023

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

Enquiries:

Β 

Catherine Stead, Company Secretary

Rentokil Initial plc

+44 (0)7826 533700

Malcolm Padley, Communications Director

Rentokil Initial plc

+44 (0)7788 978199

Peter Russell, Head of Investor Relations

Rentokil Initial plc

+44 (0)7795 166506

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHGCGDXIXDDGXX
Date   Source Headline
3rd Oct 20222:36 pmRNSBlock listing Interim Review
30th Sep 202211:42 amRNSDirector Declaration
14th Sep 20225:55 pmRNSDirector/PDMR Shareholding
14th Sep 202212:21 pmRNSDirector/PDMR Shareholding
7th Sep 20222:38 pmRNSPublication of Circular-Prospectus & GM Notice
22nd Aug 20227:00 amRNSHolding(s) in Company
5th Aug 20222:02 pmRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNS2022 Interim Results
27th Jul 20229:54 amRNSDirector Declaration
18th Jul 20223:11 pmRNSHolding(s) in Company
15th Jul 20225:30 pmRNSHolding(s) in Company
15th Jul 202211:57 amRNSHolding(s) in Company
27th Jun 20222:27 pmRNSPost stabilisation notice - Rentokil Initial Plc
22nd Jun 20224:16 pmRNSHolding(s) in Company
21st Jun 20223:37 pmRNSDirector/PDMR Shareholding
20th Jun 20229:12 amRNSPre stabilisation notice - Rentokil Initial Plc
20th May 202210:20 amRNSDirector/PDMR Shareholding
12th May 20227:00 amRNSResult of AGM
21st Apr 20227:00 amRNSQ1 Trading Update
1st Apr 20227:00 amRNSBlock listing Interim Review
31st Mar 20226:15 pmRNSTotal Voting Rights
30th Mar 20229:44 amRNSAnnual Financial Report
29th Mar 20222:20 pmRNSDirector/PDMR Shareholding
25th Mar 20224:31 pmRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSUpdate on Terminix acquisition
14th Mar 202211:00 amRNSAdditional Listing
3rd Mar 20227:00 amRNSFinal Results
2nd Mar 202210:29 amRNSDirector/PDMR Shareholding
28th Feb 20224:47 pmRNSHolding(s) in Company
22nd Dec 20215:38 pmRNSDirector/PDMR Shareholding
21st Dec 20214:09 pmRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSFurther re Terminix Acqn S&P reaffirms BBB rating
15th Dec 20212:02 pmRNSDirector/PDMR Shareholding
14th Dec 20217:00 amRNSAcquisition of Terminix by Rentokil Initial plc
22nd Oct 202110:42 amRNSDirector Declaration
21st Oct 20217:00 amRNSQ3 Trading Update
1st Oct 202110:00 amRNSBlock listing Interim Review
28th Sep 20217:00 amRNSNotice of Capital Markets Day
17th Aug 20216:09 pmRNSDirector/PDMR Shareholding
12th Aug 20214:48 pmRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSInterim Results
8th Jul 20217:00 amRNSNotice of termination of guarantee
11th Jun 20211:50 pmRNSNotice of Early Redemption
12th May 20216:03 pmRNSResult of AGM
22nd Apr 20217:00 amRNSQ1 Trading Update
7th Apr 20212:01 pmRNSDirector/PDMR Shareholding
1st Apr 20216:30 pmRNSDirector/PDMR Shareholding
1st Apr 202110:23 amRNSBlock listing Interim Review
1st Apr 202110:16 amRNSChange of Registered Office
31st Mar 20214:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.